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It is widely acknowledged that cultured myoblasts can not differentiate at very low density. Here we analyzed the
mechanism through which cell density influences myogenic differentiation in vitro. By comparing the behavior of C2C12
myoblasts at opposite cell densities, we found that, when cells are sparse, failure to undergo terminal differentiation is
independent from cell cycle control and reflects the lack of p27Kip1 and MyoD in proliferating myoblasts. We show that
inhibition of p27Kip1 expression impairs C2C12 cell differentiation at high density, while exogenous p27Kip1 allows
low-density cultured C2C12 cells to enter the differentiative program by regulating MyoD levels in undifferentiated
myoblasts. We also demonstrate that the early induction of p27Kip1 is a critical step of the N-cadherin-dependent signaling
involved in myogenesis. Overall, our data support an active role of p27Kip1 in the decision of myoblasts to commit to
terminal differentiation, distinct from the regulation of cell proliferation, and identify a pathway that, reasonably,
operates in vivo during myogenesis and might be part of the phenomenon known as “community effect”.
INTRODUCTION
Skeletal muscle cell differentiation, in vivo and in vitro,
involves irreversible withdrawal from cell cycle and expres-
sion of a number of muscle-specific genes coordinated by the
activity of muscle-specific transcription factors belonging to
the MyoD family, Myf-5, MyoD, Myogenin and MRF-4, also
known as Muscle Regulatory Factors (MRFs) (reviewed in
Molkentin and Olson, 1996; Perry and Rudnicki, 2000). The
achievement of the terminally differentiated state implies a
close functional cross-talk between MRF and cell cycle reg-
ulators. pRb and p21Cip1 were shown to play an important
role in the growth arrest of differentiating myoblasts. Their
level and/or activity are positively linked to MyoD, which
cooperates in the induction of cell cycle arrest (reviewed in
Lassar et al., 1994; Maione and Amati, 1997; Walsh and
Pearlman, 1997; Kitzmann and Fernandez, 2001; Wei and
Paterson, 2001). Moreover, in vivo studies demonstrated a
transient expression of the cyclin-dependent kinase (Cdk)
inhibitor (CKI) p27Kip1, which correlates with the timing and
expansion of the MyoD-initiated myotomal subdomain in-
dicating a short-term role of p27Kip1 as the cells are with-
drawing from the cell cycle (Zabludoff et al., 1998).
Besides the complex network controlling the execution of
myogenic program, progression of muscle-determined cells
toward stable differentiated state requires the formation of a
“community” by similar cells that allows competent cells to
respond to inductive signals (Gurdon et al., 1993; Cossu et al.,
1995; Buckingham, 2002). This phenomenon, known as
“community effect”, has a fundamental role in embryo de-
velopment as it determines proper cell differentiation within
a tissue and demarcation between tissues (Gurdon, 1988).
The community effect in in vitro myogenic differentiation is
resembled by the need for an optimal culture density in
order to achieve full muscle gene expression. The formation
of a “community” involves the establishment of cell-cell
contacts that allows intercellular signaling interactions be-
tween similar adjacent cells.
Cell-cell contact depends on the interaction of a variety of
surface molecules, whose functions have a central place in
tissue organization as well as in many responses to environ-
ment stimuli and insults. Members of the cadherin family
are regarded as the major players involved in cell-cell rec-
ognition and adhesion. It was shown that N-cadherin-de-
pendent cell interactions play a critical role in regulating the
signaling pathways required for differentiation of muscle
progenitor cells during Xenopus development (Holt et al.,
1994). In vitro studies have demonstrated that the inhibition
of N-cadherin-mediated contact perturbs muscle differenti-
ation (Knudsen et al., 1990; Mege et al., 1992; George-Wein-
stein et al., 1997; Charrasse et al., 2002). Conversely, forced
expression of N-cadherin, as well as N-cadherin engagement
achieved with different approaches, induces muscle-specific
gene expression and myogenesis in vitro (Redfield et al.,
1997; Goichberg and Geiger, 1998; Seghatoleslami et al., 2000;
Gavard et al., 2004). Although these studies reasonably in-
dicate N-cadherin-mediated signals as an important compo-
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nent of the cell-density-dependent myogenesis, they fail to
supply information on how different cell densities, which
influence entering of determined muscle cells to terminally
differentiate state, specifically affect cell cycle and myogenic
regulators.
In the present study we have investigated the mechanisms
through which cell density influences myogenic differentia-
tion in vitro and the pathway(s) involved therein. We com-
pared the behavior of C2C12 myblasts induced to differen-
tiate when dispersed or confluent. We demonstrate that
failure of C2C12 cells to terminally differentiate at low den-
sity is not associated by a defect in cell cycle exit, suggesting
the existence of a negative control of skeletal muscle differ-
entiation specifically associated with cell density and inde-
pendent from cell cycle control. On these premises we have
identified a novel and important role for the CKI p27Kip1 in
muscle differentiation concerning the maintenance of appro-
priate MyoD protein levels in proliferating myoblasts at
high density by preventing its degradation. Furthermore,
the results obtained suggest a functional link between cad-
herin-cadherin interactions, p27Kip1 and terminal differenti-
ation, and support an active role for p27Kip1 in an early stage
of the decision to enter the terminally differentiated state,
distinct from regulation of cell proliferation.
MATERIALS AND METHODS
Cells and Culture Conditions
Cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM), supple-
mented with 10% Fetal Bovine Serum (FBS) (referred to as growth medium,
GM). Muscle differentiation was induced, after 24 h in GM, by incubating cells
in DMEM supplemented with 0.5% FBS (referred to as differentiation me-
dium, DM).
C2C12 cells conditionally expressing human p27Kip1 were generated as
follow: 5 g of p3’SS plasmid (Stratagene), containing the LacI repressor and
the hygromycin resistance genes, and 5 g of pOPI3p27Kip1 plasmid (pro-
vided by J. Wyke), containing human p27Kip1 cDNA and neomycin resistance
gene, were cotransfected into C2C12 cells; clones were selected with hygro-
mycin B and G418, and screened for the ability to express p27Kip1 protein
following addition of 10 mM isopropyl--d-thiogalactoside (IPTG) to the
culture medium.
The L6C5 cells, a subclone of rat myogenic cell line L6, were provided by S.
Adamo (University of Rome “La Sapienza”). Expression of N-cadherin in
L6C5 cells was achieved by cotransfection with pBATMNC (provided by M.
Takeichi, RIKEN Center for Developmental Biology, Kobe, Japan), containing
mouse N-cadherin cDNA, and pBabeHygro (provided by H. Land, University
of Rochester Medical Center, Rochester, NY, USA) carrying the hygromycin
resistance gene (L6C5-N). Control L6C5 cells were obtained by transfection
with pBabeHygro.
C2C12A5LacI is a clone of C2C12 steadily expressing the LacI repressor of
the IPTG-inducible system (Stratagene) generated by transfecting the LacI-
repressor containing plasmid p3’SS.
Transfections were performed by DNA-calcium-phosphate coprecipitation
method.
3T3 fibroblasts from p27 knock out mice (referred to as MEF p27Kip1/)
were kindly provided by S. Coats (Amgen, Thousand Oaks, CA, USA).
Low and high density conditions were achieved by seeding isolated myo-
blasts at 5  102/cm2 and confluent myoblasts at 2  104/cm2, respectively.
Inhibition of p27Kip1 expression was achieved by lipofecting 1,5  105
C2C12 cells in 35 mm collagen-coated dishes with C-5 propyne-modified
phosphorothioate oligonucleotides, as described (Coats et al., 1996). p27Kip1-
specific antisense and mismatch oligonucleotides, as well as GS2888 cytofectin
were kindly provided by J. Wolf (Gilead Sciences).
Proteasome inhibitor MG132 (Sigma-Aldrich) was used at 50 M; Rosco-
vitine (Calbiochem) was used at 5 M.
Viruses and Infection
pBabePurop27Kip1 and pBabePurop27Kip1VPKK retroviral vectors were
kindly provided by B. Amati (European Institute of Oncology, Milan, Italy).
pBabeHygroMyoD and pBabeHygroMyoDSP3 were generated by subclon-
ing the EcoRI/HindIII fragments of murine MyoD and MyoDSP3 cDNAs from
pCB6-MyoD and pCB6-MyoDSP3 (Song et al., 1998, made available by G.
Falcone, CNR, Rome) into pBluescript IIKS plasmid (Stratagene) in antisense
orientation. The SalI/EcoRI fragments from pBluescript IIKS were EcoRI/SalI
subcloned into the retroviral vector pBabeHygro (provided by H. Land).
High titer viral stocks were obtained from the ecotropic Phoenix packaging
cell line (kindly provided by G. Nolan, Stanford University, CA, USA) tran-
siently transfected with the retroviral vectors described above.
Infection was performed in 60 mm dishes. 2105 C2C12 cells were seeded
and treated for 2 h with 3 g/ml polybrene in GM. 1 ml of viral stock was
added and infection was allowed to proceed overnight. On the next day, cells
were fed GM. Selective agents, puromycin or hygromycin B, were added on
the second day postinfection.
Immunofluorescence
Skeletal muscle Myosin Heavy Chain (MHC), p27Kip1 and Lac I expression
was revealed in cells fixed for 10 min in 3.3% para-formaldehyde and per-
meabilized with 0.25% TritonX-100 by using the following antibodies: mono-
clonal antibody (mAb) to MHC (MF20) (provided by D. Fishman, Cornell
University, New York), mAb to p27Kip1 (BD, Transduction Lab) and rabbit
polyclonal antibody to LacI (Stratagene).
Bromodeoxyuridine-labeled cells were processed as described (Grossi et al.,
1998).
FITC- and TRITC conjugated goat anti-mouse and anti-rabbit antibodies
were from Cappel (West Chester, PA).
Nuclei were stained with 0.2 g/ml DAPI.
Stained cells were examined using the Leica DMRE microscope equipped
with 20 , 40  and 100  lenses. Single images were recorded on Leica
DC250 camera and processed using the Qwin software (Leica).
Protein Extraction and Western Blot
Cells were lysed in boiling Sample Buffer 1  (50 mM Tris-HCl pH 6.8,
2%SDS, 10% glycerol, 100 mM dithiothreitol (DTT)). 30 g of protein were
resolved on 8% or 12% SDS-PAGE (according to the different molecular
weights) and then transferred onto nitrocellulose. After saturation in 5% milk
in tris-buffered saline (TBS)-T (TBS plus 0.02% Tween20), filters were incu-
bated with the following antibodies: monoclonal anti-p27Kip1 (BD, Transduc-
tion Lab); anti-Rb (PharMingen); rabbit polyclonal anti-human p27Kip1 (UBI),
anti-cycD1 (sc-718), anti-p57Kip2 (sc-8298), and anti-cycE (sc-481) from Santa
Cruz Biotechnology; rabbit polyclonal anti-MyoD antibody R3B2 (raised, in
collaboration with S. Alema`, ICB, CNR, Rome and M. Crescenzi, ISS, Rome,
against murine MyoD expressed in bacteria); monoclonal anti-MHC (MF20, a
gift of D. Fischmann); monoclonal anti-Myogenin (IF5D, Wright et al., 1989,
made available by G. Cossu, University of Rome “La Sapienza”); rabbit
polyclonal anti-p21Cip1 (provided by C. Schneider, Laboratorio Nazionale
CIB, Trieste, Italy); rabbit polyclonal anti-LacI antibody (Stratagene); mouse
monoclonal anti -tubulin (ICN). After washing, membranes were incubated
with horseradish-peroxidase-conjugated species-specific secondary antibod-
ies (BIO-RAD) followed by enhanced chemiluminescence system (Amer-
sham).
Immunoprecipitation and Kinase Activity Assays
To evaluate Cdk2 and Cdk4-associated kinase activities, cells were lysed for
30 min at 4°C in a lysis buffer containing 50 mM Tris-HCl pH 8, 150 mM NaCl,
1% Nonidet-P40, 0.5% sodium deoxycholate, 0.5 mM phenylmethylsulfo-
nylfluoride, leupeptin at 5 g/ml, aprotinin at 5 g/ml and pepstatin at 5
g/ml. Protein extracts (2 mg per sample) were incubated over night at 4°C
with 5 g of specific antibodies [anti-Cdk2 goat antiserum (M2) or anti-Cdk4
goat antiserum (C-22) from Santa Cruz Biotechnology]. The following day, 50
l of a protein G-agarose bead suspension (Pierce) was added to each sample
at 4°C for 1 h. After extensive washes, immunoprecipitates were resuspended
in 50 l of kinase buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 10 mM
-glycero phosphate, 2.5 mM EGTA, 1 mM DTT, 50 mM NaF, 50 mM sodium
orthovanadate) supplemented with 50 M unlabeled ATP, 1 g Histone H1
or 2.5 g of GST-Rb fusion protein (Santa Cruz) as substrate, and 10 Ci
[-32P]ATP per sample and incubated for 30 min at 30°C. The reactions were
stopped by adding 2  SDS loading buffer and boiling for 10 min. Labeled
proteins were resolved on an SDS-12% polyacrilammide gel and either ex-
posed to film or immunoblotted.
RNA Isolation and Northern Blot Analysis
Total RNA was prepared and analyzed by Northern blot as described (Russo
et al., 1997). To detect p27Kip1, MyoD and constitutive transcript glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), inserts were excised with the
appropriate restriction enzymes from the following plasmids and used as
probes: pETmp27, containing a 500 base pairs mouse p27Kip1 cDNA (pro-
vided by G. Del Sal, Laboratorio Nazionale CIB, Trieste, Italy); pEMC11S,
containing a 1,5Kb mouse MyoD cDNA (obtained from H. Weintraub); a
plasmid containing a 1.2 Kb cDNA of the avian GAPDH (obtained from C.
Schneider, Laboratorio Nazionale CIB, Trieste, Italy).
RESULTS
Myogenic Differentiation in Vitro Is Density-dependent
To assess the role of cell density in skeletal muscle differen-
tiation, we studied the differentiative response of the C2C12
G. Messina et al.
Molecular Biology of the Cell1470
murine myogenic cell line to different culture conditions.
Cells were plated in growth medium (GM) at two extremely
different densities: 5  102/cm2 (referred to as low density,
LD) and 2 104/cm2 (referred to as high density, HD). After
24 h, cells were shifted to differentiation medium (DM) and
maintained in DM for 3 d. Analysis of skeletal muscle my-
osin heavy chain (MHC) (Figure 1A, B and C) and Myogenin
(Figure 1C) expression revealed that only cells plated at HD
were able to terminally differentiate, while cells plated at LD
displayed a very poor differentiation potential, indicating
that cell density can deeply influence the differentiative abil-
ity of C2C12 myoblasts.
Because cell cycle progression and myogenic differentia-
tion are two very close and mutually exclusive events (Oka-
zaki and Holtzer, 1966; Nadal-Ginard, 1978), we asked
whether the failure of C2C12 cells to differentiate at LD
could be ascribed to a high proliferative rate retained in the
differentiation condition. The data shown in Figure 1D indi-
cate that LD-cultured C2C12 cells were able to exit the cell
cycle when serum deprived and that the residual percentage
of cells in S phase (17.5%) did not account for the virtually
complete absence of terminally differentiated myocites (2%,
Figure 1B).
The expression of cell cycle regulators and of MyoD was
then compared in C2C12 cells plated at LD and HD, cultured
in growth or differentiation conditions. Western blot analy-
sis (Figure 1E) shows that p21Cip1 was expressed equally at
low and at high density, increasing in DM. p57Kip2 was only
expressed in differentiated cells, confirming the tight asso-
ciation between p57Kip2 and myogenic terminal differentia-
tion (Zhang et al., 1999). p27Kip1 was undetectable in prolif-
erating C2C12 cells plated at LD (GM/LD), while it was
expressed at high levels when they were plated at HD
(GM/HD). The subsequent cultivation in DM allowed a
significant and comparable accumulation of the protein in
both culture conditions. The expression pattern of MyoD in
C2C12 cells maintained in GM at LD and HD was similar to
that of p27Kip1, while, unlike p27Kip1, MyoD levels remained
Figure 1. Myogenic differentiation in vitro is
density-dependent. C2C12 myoblasts were
seeded at low (5  102/cm2, LD) and high
(2  104/cm2, HD) density in GM. Cells were
shifted to DM the day after plating and ana-
lyzed after further 3 d. Proteins were ex-
tracted from C2C12 cells cultivated at the in-
dicated densities after 24 h in GM or after
shifting for 72 h in DM. (A) Immunofluores-
cence staining for MHC (green). Nuclei were
counterstained in blue (Dapi) and individual
pictures of the same field, taken with a DC
camera, were merged using a LEICA Micro-
systems Imaging Equipment. (B) Percentage
of nuclei belonging to MHC positive cells. (C)
Western blot analysis of differentiation asso-
ciated markers. (D) C2C12 cells were labeled
with 50 M BrdU for 2 h before shifting in
DM (GM) or after 3 d in DM (DM). Cells in S
phase were evidenced by BrdU staining. (E)
Western blot analysis of MyoD and cell cycle
regulatory proteins. Anti--tubulin antibody
was used to normalize the amount of protein
loaded. Data are the means  SD of three
independent experiments.
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very low in LD-cultured C2C12 cells in DM (compare
DM/LD with DM/HD). Figure 1E also shows that pRb was
present as hyperphosphorylated form when cells were in
GM, whether at LD or HD, and that, after shifting to DM,
protein levels increased in differentiated HD-cultured
C2C12 cells and accumulated as hypophosphorylated form,
while only the phosphorylation levels changed in LD-cul-
tured C2C12 cells, denoting growth arrest without muscle
differentiation. We also analyzed the levels of the cyc D1 and
cyc E and found that they were still expressed in C2C12 cells
at LD conditions after 3 d in DM (Figure 1E). This finding
was very surprising, since it has been shown that the ex-
pression of these proteins, especially that of cyc D1, is linked
to the presence of growth factors in the medium (Matsus-
hime et al., 1994).
To avoid the possibility that lack of terminal differentia-
tion in C2C12 cells cultured at LD was due to a delay in cell
cycle exit, we extended the analysis to 9 d after shifting in
DM and monitored DNA synthesis by BrdU labeling and
staining. We also assessed the incidence of terminally dif-
ferentiated cells at the different time points prolonging the
analysis to 11 d. The results, shown in Figure 2A, indicate
that LD-cultured C2C12 cells actually exited the cell cycle
and that the majority of the cells were growth arrested at
day 7 (T7) as assessed by 48 h BrdU labeling. The evaluation
of differentiated cells evidenced that the incidence of MHC
positive cells did not significantly increase neither at the
same time point (T7) nor during the following times ana-
lyzed, (T9), (T10), (T11) (Figure 2A). Figure 2B shows that
the expression of both p27Kip1 and MyoD proteins increased
upon shift in DM and their levels did not vary throughout
the analyzed period length. Both cyc D1 and E were found to
be still expressed in growth arrested LD C2C12 cells, while
pRb accumulated as hypophosphorylated form.
Taken together these results suggest the existence of a
negative regulatory pathway, controlling myogenic differ-
entiation, which strictly depends on cell density itself and
involves differential expression of key-regulators of both,
cell cycle and myogenic differentiation.
p27Kip1 Specifically Regulates C2C12 Cell Differentiation
Because the relationship between p27Kip1 expression and
high cell density has been documented (Hengst et al., 1994;
Polyak et al., 1994; Dietrich et al., 1997; Nakatsuji et al., 2001),
and we found that only myoblasts expressing high levels of
p27Kip1 in GM execute the full differentiative program upon
cultivation in DM, we asked whether p27Kip1 could be di-
rectly involved in the regulation of myogenic differentiation.
Two different approaches were used, aimed at providing
direct evidence for a specific role of p27Kip1 in myogenic
differentiation. In a first set of experiments we attempted to
inhibit p27Kip1 expression in HD-cultured C2C12 myoblasts
by an antisense strategy. For this purpose, cells, plated in
GM at HD, were transfected with p27Kip1-specific antisense
(AS) and mismatch (MS) oligonucleotides. 24 h later, cells
were shifted to DM. After further 48 h a set of cultures were
transfected again with the AS oligonucleotides in DM (AS/
AS), to ensure a continuous inhibition of protein expression
throughout the experiment. Figure 3 illustrates the extent of
terminal differentiation of transfected HD-cultured C2C12
cells (Figure 3A), and shows that interference with
p27Kip1expression resulted in a severe impairment of termi-
nal differentiation, achieving 96% inhibition in AS/AS (Fig-
ure 3B). Western blot analysis indicates that p27Kip1 accu-
mulation was prevented very efficiently by the AS
oligonucleotides, both in GM and in DM (Figure 3C), sug-
gesting a direct relationship between loss of p27Kip1 accu-
mulation and lack of myogenic differentiation. The inhibi-
tion of p27Kip1 in growth conditions was accompanied by
increased levels of both cyc D1 and cyc E, whose expression
was unexpectedly retained in AS transfected C2C12 cells
cultured in DM, despite growth factor deprivation (Figure
3C). Hence, we asked whether impairment of differentiation
potential and increase of G1 cyclin expression would corre-
spond to an altered growth behavior of C2C12 cells in DM.
Figure 3D shows that p27Kip1 inhibition did not interfere
with normal growth control, as MS and AS transfected cul-
tures displayed similar percentage of cells in S phase, both in
GM and in DM.
These data demonstrate that inhibiting p27Kip1 in HD
cultures strongly influences the proper execution of the
myogenic differentiation program without altering cell cycle
response to growth factor deprivation, and indicate that
p27Kip1 expression is required in order to reach a fully
differentiated state. Accordingly, it would be predicted that
forced expression of p27Kip1 in LD-cultured C2C12 cells
could mimic HD conditions and promote terminal differen-
tiation.
To achieve conditional expression of exogenous p27Kip1 in
C2C12 myoblasts, we used an inducible mammalian expres-
sion system. Cells were cotransfected with p3’SS and
Figure 2. LD-cultured C2C12 cells exit cell cycle upon serum de-
pletion. (A) C2C12 cells, seeded at low or high densities, were
labeled with 50 M BrdU for 1 h or with 20 M BrdU for 24 or 48 h
at the indicated times. Cells in S phase were evidenced by BrdU
staining. At the indicated times parallel cultures were processed for
MHC expression by immunofluorescence. (B) Proteins were ex-
tracted from C2C12 cells cultivated at low density after 24 h in GM
(0) or after shifting in DM at the indicated times. Anti--tubulin
antibody was used to normalize the amount of protein loaded. Data
are the means  SD of three independent experiments.
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pOPI3p27Kip1 expression vectors. Several clones were se-
lected and three of them (A6, B5 and C3) were chosen for the
strong induction of exogenous p27Kip1 expression upon ad-
dition of isopropyl--d-thiogalactoside (IPTG) (Figure 4A).
Inducible and control cell lines were plated at LD, the in-
ducer was added at different times and for different period
lengths and the incidence of terminally differentiated cells
was assessed after 5 d in DM (Figure 4B). Figure 4C illus-
trates the results obtained with clone A6 and shows that: i)
the presence of IPTG throughout the experiment allowed
more than 50% of the cells to undergo terminal differentia-
tion (column 4); ii) the induction of exogenous p27Kip1 ex-
pression during only the first 24 h in GM, before shifting in
DM, was sufficient to significantly enhance the proportion of
differentiated C2C12 cells (column 2); iii) the addition of
IPTG at the time of shifting in DM was ineffective (column
3). Similar results were obtained with the other two clones
(not shown). We investigated whether the acquisition of
competence for terminal differentiation was due to an addi-
tional antiproliferative effect exerted by exogenous p27Kip1.
Data from bromodeoxyuridine (BrdU) incorporation
showed that the proportion of C2C12 cells in S phase was
comparable, both in GM and DM, in IPTG treated cells as
well as in untreated cultures (Figure 4D).
Western blot analysis (Figure 4E) revealed an interesting
modulation of protein expression pattern dependent on ex-
ogenous p27Kip1. In fact, the early induction of p27Kip1 was
associated with a strong accumulation of MyoD in GM that
was probably responsible for the recovered ability of C2C12
cells to terminally differentiate at LD conditions. These find-
ings indicate that p27Kip1 is acting upstream MyoD in the
execution of the myogenic program. Another interesting
aspect focuses on the levels of cyc D1 and cyc E expression.
In fact, they were still expressed in LD-cultured C2C12 cells
in DM conditions, while their expression was significantly
down-regulated after exogenous p27Kip1 induction.
Overall these data lead to the conclusion that p27Kip1 is
required to achieve terminal differentiation with a role par-
allel to, but distinct from, cell cycle control.
At Low Cell Density p27Kip1 and MyoD Are Subject of a
Major Degradation Rate
To understand how p27Kip1 and MyoD expression was reg-
ulated at the different cell densities, we first analyzed
p27Kip1 and MyoD mRNAs by Northern Blot. Figure 5A
shows that cell density did not dramatically influence MyoD
mRNA accumulation and did not perturb p27Kip1 transcript
levels. Thus, the discrepancy between mRNA and protein
accumulation in C2C12 cells at LD suggests the existence
of a posttranscriptional regulation of MyoD and p27Kip1
expression.
Although the existence of a transcriptional control of
p27Kip1 has been demonstrated (Hengst and Reed, 1996),
different studies reported that the decrease of p27Kip1 levels
during the G1/S transition involves ubiquitin-proteasome
mediated proteolysis, which is mainly controlled by cyc E
Figure 3. p27Kip1 antisense oligonucleotides severely inhibit myogenic differentiation. C2C12 cells, plated at HD, were transfected in GM
with either p27Kip1 antisense (AS) or mismatch (MS) oligonucleotides and, after 24 h, were shifted to DM for 3 d without further treatment
(AS) or transfecting them again after 48 h in DM (MS/MS and AS/AS). (A) At the third day in DM, cells were fixed and MHC expression
was revealed by immunofluorescence staining (green). Nuclei were counterstained in blue (Dapi) and individual pictures of the same field,
taken with a DC camera, were merged using a LEICA Microsystems Imaging Equipment. (B) Percentage of nuclei belonging to MHC positive
cells. (C) Proteins were extracted from parallel cultures after 24 h in GM or 72 h in DM. Extracts normalized for protein content were blotted
and probed with antibodies specific for the indicated proteins. (D) C2C12 myoblasts, transfected as indicated, were labeled with 50 M BrdU
for 2 h after 24 h in GM or 72 h in DM. Cells in S phase were evidenced by BrdU staining. Data are the means  SD of three independent
experiments.
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-Cdk2-dependent phosphorylation on Thr187 (Pagano et al.,
1995; Vlach et al., 1997; Millard et al., 1997). Similarly it has
been demonstrated that Cdk-dependent phosphorylation of
MyoD can target it to a rapid degradation via proteasome
(Song et al., 1998), and that direct phosphorylation of MyoD
on Ser200 by cyc E-Cdk2 plays a crucial role in modulating
MyoD half-life and myogenic activity (Kitzmann et al., 1999;
Reynaud et al., 1999; Tintignac et al., 2000).
The analysis of Cdk activity in the various culture condi-
tions indicate that, despite the elevated levels of the CKI
p21Cip1 (see Figures 1 and 2), LD-cultured C2C12 cells in GM
displayed a kinase activity associated to Cdk2 higher than
HD-cultured C2C12 cells in the same culture conditions
(compare histone H1 phosphorylation with the amount of
Cdk2 in the respective immunoprecipitates), while Cdk4-
associated activity was quite comparable in GM in the two
density conditions. Moreover, Cdk2 retained a significant
residual activity in C2C12 cells cultured at low density in
DM conditions (Figures 5B). Thus, in order to verify whether
the lack of p27Kip1 and MyoD expression in LD-cultured
C2C12 cells could reflect a major degradation driven by
cycE-Cdk2-dependent phosphorylation, we examined the
effects of the proteasome inhibitor MG132, and the Cdk2-
selective inhibitor roscovitine on the accumulation of endog-
enous p27Kip1 and MyoD in cultures at LD and HD in GM
conditions. As shown in Figures 5C, addition of MG132
induced a strong accumulation of p27Kip1 and MyoD in
LD-cultured C2C12 myoblasts, while the protein levels were
unaffected in HD cultures, demonstrating that, in myoblasts
cultivated at LD, both p27Kip1 and MyoD are under a tight
posttranslational control based on degradation via protea-
some. Moreover, roscovitine treatment was very effective in
recovering both p27Kip1 and MyoD expression, suggesting a
prominent role for Cdk2-dependent phosphorylation in di-
recting them toward proteasome-dependent degradation. It
has to be noted that the residual activity of Cdk2 might be
also responsible for the lower MyoD protein in LD C2C12
cells in DM, as roscovitine exposure determines accumula-
tion of MyoD comparable to that observed in HD C2C12 in
DM (Supplemental Figure S1).
On the basis of these findings, we infected C2C12 cells
with the retroviral vectors pBPp27VPKK, carrying mutated
Figure 4. Forced expression of p27Kip1 re-
covers the ability of C2C12 myoblasts to dif-
ferentiate at low density culture conditions.
(A) Exogenous p27Kip1 expression in three en-
gineered clones determined after 24 h in GM
minus (-) or plus () IPTG. (B) A6 cells, plated
at LD, were induced to differentiate in the
absence or the presence of IPTG and MHC
expression was analyzed after 5 d by immu-
nofluorescence (green). Nuclei were counter-
stained in blue (Dapi) and individual pictures
of the same field, taken with a DC camera,
were merged using a LEICA Microsystems
Imaging Equipment. (C) Analysis of MHC
positive A6 cells following addition of IPTG
at different times: for only 24 h in GM (col-
umn 2), for 5 d in DM (column 3), or through-
out the whole experiment, 24 h in GM  5 d
in DM, (column 4). Column 1 refers to un-
treated cells. (D) The percentage of cells in S
phase was determined after 2 h BrdU labeling
(50 M) by immunofluorescence staining. (E)
Protein extracts from A6 cells grown in GM
for 24 h minus or plus IPTG or in DM for 5 d
minus or plus IPTG were probed with the
indicated antibodies. The expression of LacI
repressor was used to normalize the amount
of protein loaded. Data are the means SD of
three independent experiments.
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p27Kip1 (Val in place of Thr187), and pBHMyoDSP3 carrying
mutated MyoD (Ala in place of Ser200). Infected cells were
plated at LD, and the differentiation phenotype was ana-
lyzed after 3 d in DM and compared with that displayed by
C2C12 cells expressing exogenous wild-type alleles or in-
fected with the empty vectors (BP or BH). Figure 6A shows
that overexpression of both p27VPKK and MyoDSP3 signif-
icantly improved myogenic differentiation when compared
with overexpression of wild-type proteins. Expression of
exogenous and endogenous p27Kip1 and MyoD was also
analyzed in infected C2C12 cells kept at LD in GM. The
results pointed up two important aspects. On the one hand,
they confirm that forced expression of p27Kip at LD induces
myoblasts to terminally differentiate as a consequence of
MyoD accumulation (Figure 6B). On the other hand, as
reasonably expected, overexpression of exogenous MyoD,
either wild-type or mutated, allowed LD-cultured myoblasts
to undergo differentiation, albeit to a different extent, with-
out altering the p27Kip1 expression pattern (Figure 6C).
Figure 5. At LD conditions MyoD and p27Kip1 show a major
posttranslational control. (A) Northern Blot analysis of p27Kip1 and
MyoD transcript accumulation. (B) Kinase activities precipitated by
anti-Cdk2 or anti-Cdk4 antibodies from C2C12 at the indicated
culture conditions after 24 h in GM or after shifting for 72 h in DM
as assayed by phosphorylation of histone H1 (H1) and GST-Rb
fusion protein (Rb) respectively. The amount of Cdk2 and Cdk4 in
the immunoprecipitates was assessed by Western blot. (C) C2C12
cells, grown in GM at HD or LD were treated with either 50 M
MG132 (MG) or 5 M Roscovitine (R) for 6 h. (-) denotes treatment
with dimethyl sulfoxide. Extracts normalized for protein content
(-tubulin) were probed with antibodies specific for the indicated
proteins.
Figure 6. Stabilized mutants of p27Kip1 and of MyoD improve
terminal differentiation at LD. (A) C2C12 cells, infected with pBa-
bePuro (BP) and pBabeHygro (BH) retroviral vectors, wild-type
p27Kip1 and MyoD containing retroviral vectors or p27VPKK and
MyoDSP3 expressing retroviral vectors, were plated at LD and, after
24 h in GM, shifted to DM. 3 d later the amount of MHC positive
cells was assessed. (*) Values from p27VPKK and MyoDSP3 sam-
ples are statistically significant compared with those from the re-
spective wild-type (p 0.001). Data are the means  SD of three
independent experiments. (B) Expression levels of p27Kip1, either
wild-type or mutated, and MyoD in LD cultured C2C12 cells, in-
fected as indicated, were assessed by Western Blot after 24 h in GM.
(C) Expression levels of MyoD, either wild-type or mutated, and
p27Kip1 in LD cultured C2C12 cells, infected as indicated, were
assessed by Western Blot after 24 h in GM. Anti--tubulin antibody
was used to normalize the amount of protein loaded.
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Thus both, inhibitor treatment and overexpression of sta-
bilized mutants, point out a major posttranslational regula-
tion of p27Kip1 and MyoD at LD, and the role of Cdk2-
dependent phosphorylation in controlling protein half-life.
Moreover, data from p27Kip1 and MyoD overexpression ex-
periments support a direct relationship between p27Kip1 and
MyoD, with p27Kip1 acting upstream MyoD in coordinating
muscle terminal differentiation.
N-Cadherin-dependent Cell-Cell Contact Induces p27Kip1
Expression and Leads Myoblasts to Terminally
Differentiate at LD
To define whether the requirement of a high cell density for
a full differentiation could reflect the production of specific
factors, we cultivated C2C12 cells at LD with conditioned
medium from HD cultures. We found that it was not able to
promote terminal differentiation (data not shown), suggest-
ing that direct cell-cell contact was required.
p27Kip1 is up-regulated during growth arrest induced by
cell contact as the result of signal transduction triggered by
interactions between molecules expressed on the surface of
adjacent cells (Polyak et al., 1994). On this basis, we asked
whether such a mechanism could be responsible for p27Kip1
accumulation and terminal differentiation in HD-cultured
C2C12 cells. To address this issue we set up mixed cultures
where 5  102/cm2 (LD) myoblasts were plated together
with a large excess (2  104/cm2) of mouse fibroblasts,
which provided HD culture conditions. A schematic repre-
sentation of the experimental setting is illustrated in Figure
7A. To distinguish between murine myoblasts and fibro-
blasts in in situ analysis, we used a C2C12 cell line stably
expressing the LacI repressor from the Lac-Switch inducible
expression system (C2C12A5LacI, simply named C2C12),
while to detect p27Kip1 specifically expressed by myogenic
cells we used embryo fibroblasts from p27Kip1 knockout
mice (MEFp27/) as coculture partner. C2C12 cells were
plated at LD alone or in cocultivation with an excess of
MEFp27/ and, after 24 h in GM, were shifted to DM. As
expected, terminal differentiation was largely prevented in
single-culture myoblasts, while a large proportion (more
than 90%) of C2C12 cells in mixed culture underwent myo-
genic differentiation (Figure 7B). Moreover, the commitment
of LD-cultured C2C12 cells to differentiate in mixed culture
was associated to an early expression of p27Kip1 when cells
were still in GM (Figure 7C). To demonstrate a cause-effect
relationship between early expression of p27Kip1 in GM and
the subsequent differentiation of C2C12 cells in mixed cul-
ture, we inhibited p27Kip1 accumulation by transfecting co-
cultures with p27Kip1 AS oligonucleotides. Figure 7D shows
that the interference with p27Kip1 expression in mixed cul-
ture strongly impaired C2C12 cell differentiation. These data
demonstrate that the establishment of cell-cell contact with
surrounding fibroblasts is sufficient to induce p27Kip1 ex-
pression and allows terminal differentiation in LD-cultured
myoblasts, thus resembling HD culture conditions.
To investigate whether cadherin-mediated cell adhesion,
particularly N-cadherin, was involved in density-dependent
regulation of myogenic differentiation in vitro, we compared
the differentiative response in mixed culture of the rat myo-
genic cell line L6C5, which is defective for N-cadherin ex-
pression (Pouliot et al., 1994), to that of L6C5-N cell line, a
L6C5 derivative stably expressing mouse N-cadherin. The
data reported in Figure 8A show that: i) both cell lines failed
to undergo terminal differentiation when plated at LD (L6 and
L6-N); ii) L6C5 cells were still unable to differentiate when
plated at LD together with an excess of mouse fibroblasts, as
very few L6C5 cells expressed MHC (L6/p27/); iii) only
L6C5-N cells were responsive to HD culture conditions pro-
vided by adjacent heterologous cells and more than 50% of the
cells underwent terminal differentiation (L6-N/p27/). The
analysis of p27Kip1 expression in GM (Figure 8B) revealed that
only myoblasts expressing exogenous N-cadherin were able to
accumulate the CKI in mixed culture, suggesting a tight rela-
tionship between N-cadherin mediated adhesion, p27Kip1 ex-
pression and skeletal muscle terminal differentiation. Also in
this experimental setting the inhibition of p27Kip1 by AS oligo-
nucleotides in GM, strongly interfered with the differentiative
potential of myogenic cells (data not shown), emphasizing that
the essential prerequisite for efficient muscle differentiation is
the early expression of p27Kip1.
DISCUSSION
The results presented in this paper show that the activity of
p27Kip1 is an important part of the mechanism regulating
muscle differentiation at different cell densities and that it
concerns the maintenance of proper MyoD levels in undif-
ferentiated myoblasts. We demonstrate that p27Kip1 plays a
central role in the decision of determined myoblasts to enter
a stable differentiated state and that its function is indepen-
dent from cell cycle regulation. We also propose that p27Kip1
is a crucial effector of the N-cadherin-dependent signaling
involved in muscle-specific gene expression.
Here we show that in the context of LD conditions, deter-
mined myogenic C2C12 cells, as well as other myogenic cell
lines and primary quail myoblasts (G. Messina, unpublished
observations), although cell cycle arrested, are not able to
achieve complete differentiation. The analysis of myogenic
and cell cycle regulators revealed that a substantial differ-
ence between LD and HD cultures resides, under growth
conditions, in the expression levels of MyoD and p27Kip1.
The absence of p27Kip1 in GM at LD is expected, as its
expression has been described to be positively influenced by
cell-cell contact, in addition to serum deprivation (Hengst et
al., 1994; Polyak et al., 1994). On the contrary, it was surpris-
ing to find undetectable levels of MyoD in growth condi-
tions, as it is usually expressed both in proliferating and
differentiated C2C12 cells. On the whole, the comparison of
the expression pattern displayed by C2C12 cells at the two
different cell densities highlights a possible functional link
between lack of p27Kip1 and MyoD expression in GM and
the lack of full myogenic commitment in sparse cultures.
While the role of p27Kip1 in cell cycle control is extensively
documented, its possible specific involvement in myogenic
commitment has never been invoked. In this study we dem-
onstrated, by loss- and gain-of function approaches, that
p27Kip1 is directly involved in the circuit that regulates the
progression into a fully differentiated state, and that such a
function is independent from its ability to control cell cycle
exit. On the basis of the data presented it is apparent that
p27Kip1 function is needed in a temporally defined window
before exposure to differentiation stimuli, since induction of
the protein limited to the 24 h before shifting cells to DM is
sufficient to achieve differentiation in LD-cultured C2C12
cells. On the contrary, induction of exogenous p27Kip1 ex-
pression in DM is ineffective, suggesting that p27Kip1 plays
an important role in coordinating the decision to undergo
full myogenic commitment and in driving cells toward a
differentiative fate in response to appropriate stimuli.
Prompted by the results we have presented an essential
question might be asked: what is, beyond cell cycle control,
the relationship between p27Kip1 and the execution of the
myogenic differentiation program? An important player that
appears to be in between is the muscle regulatory factor
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MyoD, whose levels in growth conditions, and partially in
differentiation conditions, are influenced by cell density to
the same extent of p27Kip1, and whose expression is modu-
lated by exogenous p27Kip1. MyoD expression is mostly
regulated at the transcriptional level, and in our experimen-
tal setting, the lower mRNA levels detected in C2C12 cells is
certainly responsible for the decreased accumulation of
MyoD protein at LD. However, we find that, at LD, post-
translational regulation significantly contributes to modu-
late MyoD accumulation, as proteasome inhibitor treatment
allows recovery of protein levels comparable to those ob-
served in C2C12 cells at HD. It has been previously reported
that MyoD half-life and myogenic activity are influenced by
its phosphorylation state. Particularly, it has been described
that Ser 200 is a target of cyc E-Cdk2 (Tintignac et al., 2000)
and that the action of p57Kip2 in differentiating C2C12 cells
contrasts this activity (Reynaud et al., 1999). The data we
report suggest that a similar regulation occurs in C2C12 cells
cultured in GM at LD, as treatment with roscovitine deter-
mines a significant accumulation of MyoD protein when
Figure 7. Cell-cell contact with fibroblasts is sufficient to induce terminal differentiation of C2C12 cells cultured at LD. (A) Schematic
representation of the experimental setting: C2C12A5LacI (simply named C2C12) cells cultured alone at LD (C2C12LD) or in mixed culture
with an excess of mouse embryo fibroblasts from p27Kip1 knock out mice (C2C12LD/p27/). (B) C2C12 cells seeded as shown in (A) were
shifted to DM 24 h after plating. 3 d later the incidence of differentiated C2C12 cells were evaluated by MHC staining. Data are the means 
SD of three independent experiments. (C) p27Kip1 expression in C2C12 myoblasts cultured at LD alone or in mixed culture with MEFp27/
after 24 h in GM. Nuclei were counterstained in blue (Dapi); the pink colored nuclei result from the overlapping of the red (anti-p27Kip1) and
blue (DAPI) colors and represent the double-stained cells. (D) C2C12LD/p27/ mixed cultures were transfected in GM with p27Kip1
antisense (AS) or mismatch (MS) oligonucleotides and shifted to DM after 24 h. 3 d later the incidence of differentiated C2C12 cells was
evaluated by MHC staining. Data are the means  SD of three independent experiments.
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cells are cultured at LD, while MyoD levels are not affected
in HD cultures in GM, i.e., in the presence of p27Kip1, by
neither inhibitors. It is reasonable that the role exerted by
p27Kip1 on the execution of muscle differentiation concerns
with the improvement of MyoD stability, by likely inhibiting
cycE-Cdk2 activity, and that its absence in LD-cultured
C2C12 cells determines a severely reduced accumulation of
the MRF and, as a consequence, failure to terminally differ-
entiate when transferred in DM. Cdk2 activity is also instru-
mental for controlling MyoD growth suppressive effects in
growing myoblasts (Tintignac et al., 2000). Our data suggest
that, although MyoD amount must be controlled in prolif-
erating myoblasts, the decrease under threshold levels hin-
ders myogenic cells to undergo terminal differentiation. This
seems to be directly related to the activity of p27Kip1 rather
than p57Kip2. Indeed, in our culture conditions p57Kip2 ex-
pression is undetectable in growth conditions, while it in-
creases upon differentiation, as also previously reported
(Reynaud et al., 1999). Results from the over expression of
wild-type and degradation-resistant forms of p27Kip1 and
MyoD confirm a specific role of p27Kip1 in promoting termi-
nal differentiation as a direct consequence of induced MyoD
accumulation in growth conditions. Therefore, it is conceiv-
able that p27Kip1 and p57Kip2, although both involved in
MyoD stabilization, act at different stages: at the decision to
enter differentiation program and during terminal differen-
tiation, respectively.
Concerning the role of the CKIs in in vivo myogenesis,
gene disruption studies showed that they are mostly redun-
dant (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al.,
1996; Deng et al., 1995; Serrano et al., 1996; Zhang et al., 1997),
and that only the loss of p57Kip2 significantly affects skeletal
muscle differentiation (Zhang et al., 1997). The use of double
mutant mice lacking p21Cip1 and p57Kip2, has provided ev-
idence of cooperation between these two CKIs in the control
of tissue growth and development (Zhang et al., 1999). In
particular, the authors showed that mice lacking both
p21Cip1 and p57Kip2 displayed defects in skeletal muscle in
secondary myogenesis after Myogenin expression. On the
contrary, the double p27Kip1 and p57Kip2 knockout mice
apparently do not display defects in myogenesis more se-
vere than those seen in p57Kip2-null embryos (Zhang et al.,
1998).
In the light of these studies, our hypothesis envisages
p27Kip1 as a necessary factor in the initial phases of myo-
genic differentiation, supported, and then substituted, in its
function by the other members of the Cip1/Kip1 family and,
probably, by the INK4 proteins. This view seems to be
consistent with in vivo observations (Zabludoff et al., 1998)
demonstrating that during myogenesis the initial CKI activ-
ity is represented by p27Kip1 and that subsequent signals
transfer Cdk inhibition to other single or multiple CKIs. If
this simple model is correct, it implies that any muscle
phenotype in p27Kip1 knockout mice would be subtle, in-
volving changes in the timing of cell cycle exit at the onset of
differentiation, or in the level of MRF needed to initiate
differentiation.
In the present study, by setting up culture conditions
allowing protein expression patterns to be transiently mod-
ulated, we could point up a novel level of muscle differen-
tiation control regulating the decision of determined myo-
blasts to enter terminal differentiation and depending on
p27Kip1 expression and activity. On the basis of the data
presented, this activity appears to be linked to the inhibition
of Cdk2. However, roles for p27Kip1, other than Cdk inhib-
itor, have been proposed (Hauser et al., 1997; Zhang et al.,
2003; reviewed in Coqueret, 2003), and we do not exclude
additional functions for p27Kip1 in myogenesis regulation.
Indeed, very preliminary observations indicate that a
p27Kip1 mutant deficient in its interaction with both cyc E
and Cdk2 was still partially able to promote differentiation
Figure 8. N-cadherin-mediated cell-cell contact allows p27Kip1 ac-
cumulation and terminal differentiation in LD myoblasts. (A) L6C5
and L6C5-N rat myogenic cells were plated at LD alone (L6 and
L6-N) or in mixed culture with an excess of MEFp27/ (L6/
p27/ and L6-N/p27/) and, after 24 h in GM, were placed in
DM for 4 d. The incidence of differentiated cells was evaluated by
MHC staining. (B) The expression of p27Kip1 was detected after 24 h
in GM by immunofluorescence with specific antibodies. Nuclei
were counterstained in blue (Dapi). The pink colored nuclei result
from the overlapping of the red (anti-p27Kip1) and blue (DAPI)
colors. Rat nuclei (*) can be distinguished from mouse nuclei char-
acterized by intensely fluorescent chromocenters.
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of LD C2C12 cells, suggesting that p27Kip1 is probably acting
also through noncanonical pathway(s) in addition to the
well known Cdk inhibition (G. Messina, unpublished obser-
vations).
The important question now is: which are the molecules/
pathways involved in the control of p27Kip1 levels that are
missed in C2C12 cells cultured at LD? Among the possible
mechanisms, we observed that the establishment of direct
cell-cell contact plays an important role in determining
p27Kip1 accumulation and muscle terminal differentiation.
By using different cell combinations in mixed culture ap-
proaches we also found that N-cadherin-dependent cell-cell
adhesion is part of the mechanism responsible for p27Kip1
expression in myoblasts cultured at HD, a function lost in
LD cultures where cell-cell contact is prevented. It has been
already described that p27Kip1 is an effector of the cell con-
tact-induced cell cycle inhibition (Hengst et al., 1994; Polyak
et al., 1994) and that it is part of N-cadherin-mediated contact
inhibition of cell growth (Levenberg et al., 1999). Further-
more, many different studies suggest that N-cadherin-medi-
ated adhesion is directly involved in muscle differentiation
in vitro (Goichberg and Geiger, 1999, Charrasse et al., 2002;
Gavard et al., 2004). In this regard, it has been described how
N-cadherin-dependent cell-cell contact regulates muscle-
specific gene expression through the Rho GTPase pathway
(Charrasse et al., 2002). The authors hypothesize that, by
modulating Rho GTPase activity, N-cadherin-mediated cell
adhesion influences muscle-specific gene expression, includ-
ing MyoD transcription, which, in turn, would control CKI-
dependent cell-cycle arrest.
Although data from our mixed culture experiments con-
firm these observations, the results obtained from p27Kip1
and MyoD overexpression in LD-cultured C2C12 cells
strongly suggest that p27Kip1 acts upstream MyoD, probably
influencing its half-life. Hence, the data we have presented
allow us to propose a model in which the establishment of
N-cadherin-mediated cell-cell contact promotes p27Kip1 ex-
pression, which in turn supports MyoD accumulation and
terminal differentiation. It must be underlined that the major
activity of p27Kip1 occurs in a defined temporal window,
when a growing myoblast has to decide, upon appropriate
stimuli, whether to undertake terminal differentiation or not,
and that the presence of p27Kip1 is required within that time
window in order to maintain sufficient MyoD levels that will
allow myoblasts to enter the terminal differentiative pro-
gram.
In conclusion, our data highlight a specific role for the CKI
p27Kip1 in skeletal muscle differentiation controlling pro-
gression from determined to fully differentiated state by
regulating MyoD half-life, and show that an appropriate cell
density is required in order to achieve full execution of the
differentiative program, that reflects the expression of
p27Kip1 primed by cadherin-mediated cell adhesion among
many nearby similar cells. Such a pathway would constitute
an integral part of the “community effect”, observed in vivo,
which governs myogenesis and determines the precise tem-
poral and spatial placement of body muscle formation.
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